# ChatTogoVar

The variant **rs121913279** appears to involve **dominant pathogenic effects** based on its associations with several conditions. It is primarily linked to diseases involving somatic mutations, such as various cancers and overgrowth syndromes. Notably, the variant impacts the **PIK3CA** gene—a critical gene in the PI3K/AKT signaling pathway often implicated in tumorigenesis. Here's why this variant behaves in a dominant manner:

1. **Disease Associations and Inheritance Patterns**:
   - **Dominant effects** are evident in conditions like cancers (e.g., colorectal cancer, non-small cell lung carcinoma, breast adenocarcinoma) and overgrowth syndromes (e.g., CLOVES syndrome, PIK3CA-related overgrowth syndrome). These are typically caused by somatic mutations with gain-of-function consequences rather than recessive modes of inheritance.
   - In somatic contexts, a single mutated copy of this allele tends to activate oncogenic signaling, which is characteristic of dominant molecular effects.

Source for variant associations:
- TogoVar ClinVar: [VCV000013652 (A>G)](https://www.ncbi.nlm.nih.gov/clinvar/variation/13652), [VCV000013653 (A>T)](https://www.ncbi.nlm.nih.gov/clinvar/variation/13653)

2. **Functional Predictions**:
   - The **His1047Arg (A>G)** substitution in **PIK3CA** is gain-of-function and enhances the gene’s oncogenic signaling potential, which is a hallmark of dominant somatic mutations linked to cancer.
   - Tools like **SIFT**, **Polyphen**, and **AlphaMissense** predict functional impacts with strong evidence of pathogenicity, consistent with dominant phenotypes.

3. **Zygosity Information**:
   - While germline inheritance patterns are not directly noted, the pathogenic effects in somatic cases do not rely on the presence of two mutated alleles (recessive). A single copy change suffices for phenotype development in dominant conditions.

In conclusion, **rs121913279** exhibits **dominant behavior** in its pathogenic mechanisms, particularly in the context of somatic mutations and oncogenic diseases.

For additional insights, visit [TogoVar entry for rs121913279](https://togovar.biosciencedbc.jp/en/variant/tgv15260121).